MITOXCEL Trademark

Trademark Overview

On Thursday, June 12, 2025, a trademark application was filed for MITOXCEL with the United States Patent and Trademark Office. The USPTO has given the MITOXCEL trademark a serial number of 99230621. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 12, 2025. This trademark is owned by SENOTHERAPEUTIX, Inc.. The MITOXCEL trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Synthetic peptides for the treatment of cancer, age-related disorders, age-related diseases, skin conditions, radiation damage, obesity, mitochondrial disease, neurodegenerative disease, and metabolic conditions; Pharmaceutical preparations for the prevention of and treatment of cancer, age-related disorders, age-related diseases, skin conditions, radiation damage, obesity, mitochondrial disease, neurodegenerative disease, and metabolic conditions; Pharmaceutical preparations for gene therapy for the treatment of age-related disorders; Pharmaceutical preparations for gene therapy for the treatment of cancer; Medicated skin preparation for use in treating skin conditions, aging, mitochondrial conditions, and senescent cells

Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of cancer, age-related disorders, age-related diseases, skin conditions, radiation damage, obesity, mitochondrial disease, neurodegenerative disease, and metabolic conditions; Medical services in the field of mitochondrial health and mitochondrial disease; Medical services in the field of metabolic health and metabolic conditions; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical services in the field of neurodegenerative health and neurodegenerative disease; Medical advisory services; Medical testing services; Medical testing services relating to the diagnosis and treatment of disease

Medical research services; Medical research in the field of mitochondrial health and mitochondrial disease; Medical research services in the field of metabolic health and metabolic conditions; Medical research services in the field of anti-aging; Medical research services in the field of senescent cells; Medical research services in the field of age-related disorders; Medical research services in the field of neurodegenerative health and neurodegenerative disease; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Gene therapy research; Testing of pharmaceuticals for cell and gene therapies; Development of pharmaceuticals for cell and gene therapies; Pharmaceutical research in the field of mitochondrial disease; Pharmaceutical research in the field of metabolic conditions; Pharmaceutical research in the field of neurodegenerative disease
mitoxcel

General Information

Serial Number99230621
Word MarkMITOXCEL
Filing DateThursday, June 12, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, June 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesSynthetic peptides for the treatment of cancer, age-related disorders, age-related diseases, skin conditions, radiation damage, obesity, mitochondrial disease, neurodegenerative disease, and metabolic conditions; Pharmaceutical preparations for the prevention of and treatment of cancer, age-related disorders, age-related diseases, skin conditions, radiation damage, obesity, mitochondrial disease, neurodegenerative disease, and metabolic conditions; Pharmaceutical preparations for gene therapy for the treatment of age-related disorders; Pharmaceutical preparations for gene therapy for the treatment of cancer; Medicated skin preparation for use in treating skin conditions, aging, mitochondrial conditions, and senescent cells
Goods and ServicesMedical services, namely, anti-aging services; Medical services, namely, prevention and treatment of cancer, age-related disorders, age-related diseases, skin conditions, radiation damage, obesity, mitochondrial disease, neurodegenerative disease, and metabolic conditions; Medical services in the field of mitochondrial health and mitochondrial disease; Medical services in the field of metabolic health and metabolic conditions; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical services in the field of neurodegenerative health and neurodegenerative disease; Medical advisory services; Medical testing services; Medical testing services relating to the diagnosis and treatment of disease
Goods and ServicesMedical research services; Medical research in the field of mitochondrial health and mitochondrial disease; Medical research services in the field of metabolic health and metabolic conditions; Medical research services in the field of anti-aging; Medical research services in the field of senescent cells; Medical research services in the field of age-related disorders; Medical research services in the field of neurodegenerative health and neurodegenerative disease; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Gene therapy research; Testing of pharmaceuticals for cell and gene therapies; Development of pharmaceuticals for cell and gene therapies; Pharmaceutical research in the field of mitochondrial disease; Pharmaceutical research in the field of metabolic conditions; Pharmaceutical research in the field of neurodegenerative disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 12, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 12, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSENOTHERAPEUTIX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events

Event DateEvent Description
Thursday, June 12, 2025NEW APPLICATION ENTERED
Thursday, June 12, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

mitoxcel medical services field disease research conditions related mitochondrial neurodegenerative metabolic